Vulnerability in Philips Intellispace Cardiovascular
CVE-2018-5438
Philips ISCV application prior to version 2.3.0 has an insufficient session expiration vulnerability where an attacker could reuse the session of a previously logged in user. This vulnerability exists when using ISCV together with an Electronic Medical Record (EMR) system, where ISCV is in KIOSK mode for multiple users and using Windows authentication. This may allow an attacker to gain unauthorized access to patient health information and potentially modify this information.
Published · last modified .
CVSS v3 metric
CVSS v3 base score 6.3 (Medium). Vector: CVSS:3.0/AV:L/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:N.
EPSS exploit prediction
EPSS: 0.004 (35.6th percentile), scored .
Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 36th percentile — 35.6% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.004 · newest: 0.004 · change: 0.000
Affected products
Weakness classification (CWE)
References
- www.usa.philips.com/healthcare/about/customer-support/product-security (Mitigation, Vendor Advisory)
- ics-cert.us-cert.gov/advisories/ICSMA-18-025-01 (US Government Resource, Third Party Advisory, Mitigation)
- www.securityfocus.com/bid/102847 (VDB Entry, Third Party Advisory, vdb-entry)
Frequently asked questions
- What is CVE-2018-5438?
- CVE-2018-5438 is a medium-severity vulnerability in Philips Intellispace Cardiovascular, classified under Insufficient Session Expiration. CVSS score: 6.3/10. Published 2018-03-20.
- How severe is CVE-2018-5438?
- Medium severity. CVSS v3 base score is 6.3 out of 10.